Last A$0.39 AUD
Change Today +0.03 / 8.33%
Volume 634.5K
As of 2:10 AM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

impedimed ltd (IPD) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/2/14 - A$0.40
52 Week Low
11/1/13 - A$0.15
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IMPEDIMED LTD (IPD)

Related News

No related news articles were found.

impedimed ltd (IPD) Related Businessweek News

No Related Businessweek News Found

impedimed ltd (IPD) Details

ImpediMed Limited develops, manufactures, and sells bioimpedance and bioimpedance spectroscopy devices, and consumables for clinicians and allied health professionals in Australia, Canada, Mexico, The United States, and internationally. The company operates through Medical, and Test & Measurement segments. The Medical segment offers non-invasive medical devices for the assessment and monitoring of secondary lymphoedema, general health assessment and weight management, muscle wasting, drug dosing and monitoring, and sports medicine and fitness, as well as body composition and hydration. The Test & Measurement segment supplies power precision testing and measuring equipment. The company offers its products through distributors. ImpediMed Limited was founded in 1999 and is based in Pinkenba, Australia.

Founded in 1999

impedimed ltd (IPD) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: A$571.1K
Chief Financial Officer
Total Annual Compensation: A$282.2K
Vice President of Global Commercialization
Total Annual Compensation: A$313.4K
Vice President of Product Development, Qualit...
Total Annual Compensation: A$267.7K
Vice President of Regulatory, Clinical Affair...
Total Annual Compensation: A$267.7K
Compensation as of Fiscal Year 2014.

impedimed ltd (IPD) Key Developments

ImpediMed Limited Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 01:30 PM

ImpediMed Limited Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 01:30 PM. Venue: Rydges Lakeland Resort, Queenstown, New Zealand. Speakers: Richard Carreon, Chief Executive Officer and President.

ImpediMed Limited, Annual General Meeting, Nov 11, 2013

ImpediMed Limited, Annual General Meeting, Nov 11, 2013.

Impedimed Limited Announces Management Changes, Effective November 11, 2013

ImpediMed Limited announced the appointment of a second US Director to the Board. David Adams will join the ImpediMed Board at the AGM on November 11, 2013 upon the retirement of founding chairman Mel Bridges. Mr. Adams held previous roles at Medtronic as Vice President, Cardiovascular Business Development; Vice President Vascular Business Development and Ventures, as well as management roles in financial planning and analysis.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPD:AU A$0.39 AUD +0.03

IPD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IPD.
View Industry Companies

Industry Analysis


Industry Average

Valuation IPD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 21.7x
Price/Book 5.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 20.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPEDIMED LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at